We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Blood pressure medications do not increase the risk of contracting COVID-19 or of serious illness or death in COVID-19 patients as previously thought, three large observational studies showed. Read More
Patients on a shorter dosing regimen in Gilead’s phase 3 remdesivir trial saw clinical improvements similar to those on the 10-day treatment schedule, the drugmaker announced Wednesday, offering hope of a COVID-19 treatment. Read More